Coherus BioSciences Reports Fourth Quarter and Full Year 2016 Corporate Highlights and Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Coherus BioSciences Reports Fourth Quarter and Full Year 2016 Corporate Highlights and Financial Results

Coherus BioSciences (CHRS) Misses Q2 EPS by 60c

March 13, 2017 4:02 PM EDT

Coherus BioSciences (NASDAQ: CHRS) reported Q2 EPS of ($1.71), $0.60 worse than the analyst estimate of ($1.11). Revenue for the quarter came in at $844 thousand, versus $10.2 million reported last year.

For earnings history and earnings-related data on Coherus BioSciences (CHRS) click here.

... More